Kashani-Sabet M - Search Results

1

Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures.

Chang SH, Ice RJ, Chen M, Sidorov M, Woo RWL, Rodriguez-Brotons A, Jian D, Kim HK, Kim A, Stone DE, Nazarian A, Oh A, Tranah GJ, Nosrati M, de Semir D, Dar AA, Desprez PY, Kashani-Sabet M, Soroceanu L, McAllister SD. Chang SH, et al. Among authors: kashani sabet m. Mol Cancer Ther. 2023 Sep 5;22(9):1100-1111. doi: 10.1158/1535-7163.MCT-22-0486. Mol Cancer Ther. 2023. PMID: 37440705

2

Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult mice.

Kashani-Sabet M, Liu Y, Fong S, Desprez PY, Liu S, Tu G, Nosrati M, Handumrongkul C, Liggitt D, Thor AD, Debs RJ. Kashani-Sabet M, et al. Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3878-83. doi: 10.1073/pnas.002025599. Epub 2002 Mar 12. Proc Natl Acad Sci U S A. 2002. PMID: 11891271 Free PMC article.

3

Tumor vascularity in the prognostic assessment of primary cutaneous melanoma.

Kashani-Sabet M, Sagebiel RW, Ferreira CM, Nosrati M, Miller JR 3rd. Kashani-Sabet M, et al. J Clin Oncol. 2002 Apr 1;20(7):1826-31. doi: 10.1200/JCO.2002.07.082. J Clin Oncol. 2002. PMID: 11919240

4

Altered clinical course of malignant melanoma in HIV-positive patients.

Rodrigues LK, Klencke BJ, Vin-Christian K, Berger TG, Crawford RI, Miller JR 3rd, Ferreira CM, Nosrati M, Kashani-Sabet M. Rodrigues LK, et al. Arch Dermatol. 2002 Jun;138(6):765-70. doi: 10.1001/archderm.138.6.765. Arch Dermatol. 2002. PMID: 12056957

5

Functional identification of distinct sets of antitumor activities mediated by the FKBP gene family.

Fong S, Mounkes L, Liu Y, Maibaum M, Alonzo E, Desprez PY, Thor AD, Kashani-Sabet M, Debs RJ. Fong S, et al. Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14253-8. doi: 10.1073/pnas.2332307100. Epub 2003 Nov 11. Proc Natl Acad Sci U S A. 2003. PMID: 14612567 Free PMC article.

6

NF-kappa B in the vascular progression of melanoma.

Kashani-Sabet M, Shaikh L, Miller JR 3rd, Nosrati M, Ferreira CM, Debs RJ, Sagebiel RW. Kashani-Sabet M, et al. J Clin Oncol. 2004 Feb 15;22(4):617-23. doi: 10.1200/JCO.2004.06.047. J Clin Oncol. 2004. PMID: 14966085

7

Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.

Nosrati M, Li S, Bagheri S, Ginzinger D, Blackburn EH, Debs RJ, Kashani-Sabet M. Nosrati M, et al. Clin Cancer Res. 2004 Aug 1;10(15):4983-90. doi: 10.1158/1078-0432.CCR-04-0134. Clin Cancer Res. 2004. PMID: 15297398

8

The role of microsatellites as a prognostic factor in primary malignant melanoma.

Shaikh L, Sagebiel RW, Ferreira CM, Nosrati M, Miller JR 3rd, Kashani-Sabet M. Shaikh L, et al. Arch Dermatol. 2005 Jun;141(6):739-42. doi: 10.1001/archderm.141.6.739. Arch Dermatol. 2005. PMID: 15967920

9

Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.

Rangel J, Torabian S, Shaikh L, Nosrati M, Baehner FL, Haqq C, Leong SP, Miller JR 3rd, Sagebiel RW, Kashani-Sabet M. Rangel J, et al. J Clin Oncol. 2006 Oct 1;24(28):4565-9. doi: 10.1200/JCO.2006.07.3833. J Clin Oncol. 2006. PMID: 17008696

10

Telomerase: going beyond the ends.

De Semir D, Nosrati M, Li S, Kashani-Sabet M. De Semir D, et al. Cell Cycle. 2007 Mar 1;6(5):546-9. doi: 10.4161/cc.6.5.3980. Epub 2007 Mar 5. Cell Cycle. 2007. PMID: 17312399 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page